Tomonari Suda1, Hiroaki Kobayashi2, Toshiharu Akiyama3, Takuya Takano4, Misa Gokyu5, Takeaki Sudo5, Thatawee Khemwong5, Yuichi Izumi6. 1. Reseach Associate, Peirodontology, Department of Bio-Matrix, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan . 2. Lecturer, Peirodontology, Department of Bio-Matrix, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan . 3. Registered Dentist, Periodontology, Department of Bio-Matrix, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan . 4. Research Student, Periodontology, Department of Bio-Matrix, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan . 5. Graduate Student, Periodontology, Department of Bio-Matrix, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan . 6. Professor, Periodontology, Department of Bio-Matrix, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan .
Abstract
BACKGROUND: Dentin hypersensitivity can interfere with optimal periodontal care by dentists and patients. The pain associated with dentin hypersensitivity during ultrasonic scaling is intolerable for patient and interferes with the procedure, particularly during supportive periodontal therapy (SPT) for patients with gingival recession. AIM: This study proposed to evaluate the desensitizing effect of the oxalic acid agent on pain caused by dentin hypersensitivity during ultrasonic scaling. MATERIALS AND METHODS: This study involved 12 patients who were incorporated in SPT program and complained of dentin hypersensitivity during ultrasonic scaling. We examined the availability of the oxalic acid agent to compare the degree of pain during ultrasonic scaling with or without the application of the dentin hypersensitivity agent. Evaluation of effects on dentin hypersensitivity was determined by a questionnaire and visual analog scale (VAS) pain scores after ultrasonic scaling. The statistical analysis was performed using the paired Student t-test and Spearman rank correlation coefficient. RESULTS: The desensitizing agent reduced the mean VAS pain score from 69.33 ± 16.02 at baseline to 26.08 ± 27.99 after application. The questionnaire revealed that >80% patients were satisfied and requested the application of the desensitizing agent for future ultrasonic scaling sessions. CONCLUSION: This study shows that the application of the oxalic acid agent considerably reduces pain associated with dentin hypersensitivity experienced during ultrasonic scaling. This pain control treatment may improve patient participation and treatment efficiency.
BACKGROUND: Dentin hypersensitivity can interfere with optimal periodontal care by dentists and patients. The pain associated with dentin hypersensitivity during ultrasonic scaling is intolerable for patient and interferes with the procedure, particularly during supportive periodontal therapy (SPT) for patients with gingival recession. AIM: This study proposed to evaluate the desensitizing effect of the oxalic acid agent on pain caused by dentin hypersensitivity during ultrasonic scaling. MATERIALS AND METHODS: This study involved 12 patients who were incorporated in SPT program and complained of dentin hypersensitivity during ultrasonic scaling. We examined the availability of the oxalic acid agent to compare the degree of pain during ultrasonic scaling with or without the application of the dentin hypersensitivity agent. Evaluation of effects on dentin hypersensitivity was determined by a questionnaire and visual analog scale (VAS) pain scores after ultrasonic scaling. The statistical analysis was performed using the paired Student t-test and Spearman rank correlation coefficient. RESULTS: The desensitizing agent reduced the mean VAS pain score from 69.33 ± 16.02 at baseline to 26.08 ± 27.99 after application. The questionnaire revealed that >80% patients were satisfied and requested the application of the desensitizing agent for future ultrasonic scaling sessions. CONCLUSION: This study shows that the application of the oxalic acid agent considerably reduces pain associated with dentin hypersensitivity experienced during ultrasonic scaling. This pain control treatment may improve patient participation and treatment efficiency.